Second cancer frequently diagnosed in men; prostate cancer is responsible for high mortality. His prognosis has
benefited from significant technical improvements. Determining prognostic factors in prostate cancer is an integral part of the therapeutic decision-making process. The aim of this study was to determine the prognostic factors of prostate cancer in the cancer department of University Hospital of Brazzaville in Congo. This was a retrospective descriptive study, which took place from 1 January 2016 to 31 December 2020, in the cancer department of the University Hospital of Brazzaville in Congo. During the study period, 118 files were retained. The survival curves were realized according to the Kaplan-Meier model, and the statistical comparison according to the Log-Rank model. The significance threshold was set at 5%. The results found that mean age was 68 ± 7.74 years. Low urinary tract symptoms accounted for 68.64% of the discovery circumstances. The Initial PSA was greater than 100 ng/ml in 65.25% of patients. Metastases were found in 95.76% of patients. Overall survival at 3 years was 15%. Survival differed significantly by age (p = 0.0017); WHO performance status (p = 0.0000); clinical stage (p = 0.0000) and metastatic site (p = 0.0022). Finally, the incidence of prostate cancer is increasing worldwide, hence the interest of defining a screening strategy, allowing to institute management with better results.

Prostate Cancer Prognostic Factors